4//SEC Filing
Estrem Paul 4
Accession 0000899243-18-016625
CIK 0001461993other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:48 PM ET
Size
9.4 KB
Accession
0000899243-18-016625
Insider Transaction Report
Form 4
Estrem Paul
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-06-12+76,000→ 76,000 totalExercise: $7.45Exp: 2028-04-20→ Common Stock (76,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the compensation committee of the Company's board of directors on April 20, 2018, subject to stockholder approval of an amendment to the stock option plan under which the option was granted. The Company's stockholders approved the plan amendment on June 12, 2018.
- [F2]One-quarter of the options will vest and become exercisable on April 20, 2019 and the remainder will vest and become exercisable in substantially equal monthly installments during the three year period commencing on April 20, 2019.
Issuer
MELINTA THERAPEUTICS, INC. /NEW/
CIK 0001461993
Entity typeother
Related Parties
1- filerCIK 0001722374
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:48 PM ET
- Size
- 9.4 KB